REFRACTORY CHRONIC MYELOMONOCYTIC LEUKEMIA

Clinical trials for REFRACTORY CHRONIC MYELOMONOCYTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY CHRONIC MYELOMONOCYTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for REFRACTORY CHRONIC MYELOMONOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 9 Not yet finished but already full! 2 Terminated 1

New drug combo tested for tough blood cancers in older adults

Disease control Terminated

This study tested how well two chemotherapy drugs, venetoclax and decitabine, work together to control aggressive blood cancers. It was for older adults newly diagnosed with acute myeloid leukemia (AML) or people whose AML or high-risk myelodysplastic syndrome (MDS) had returned …

Matched conditions: REFRACTORY CHRONIC MYELOMONOCYTIC LEUKEMIA

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 31, 2026 12:10 UTC

REFRACTORY CHRONIC MYELOMONOCYTIC LEUKEMIA

Get alerted when new REFRACTORY CHRONIC MYELOMONOCYTIC LEUKEMIA trials appear

New drug combo tested for tough blood cancers in older adults